What happened to this company? Was sitting around $5 not long ago. All I see is news on a $3M round of funding (debt) recently. Their annual report was OK (not the worst, not the best) for a company trying to develop a market for an FDA approved product that works.
Just trying to understand what is happening here before I purchase any shares? Is this a gift horse at $1 or a dead horse?
Thx, The Boxsterfan Dean Janes is king of Angry Birds!!
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.